Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis

被引：0
|
作者：
Mentz, R. [1 ]
Anker, S. [2 ]
Pitt, B. [3 ]
Rossing, P. [4 ]
Ruilope, L. [5 ,6 ]
Gebel, M. [7 ]
Kolkhof, P. [8 ]
Lawatscheck, R. [9 ]
Rohwedder, K. [10 ]
Bakris, G. [11 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC USA
[2] Charite Univ Med Berlin, Dept Cardiol CVK, German Heart Ctr Charite, Berlin, Germany
[3] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[4] Steno Diabet Ctr, Herlev, Denmark
[5] Inst Res Imas12, Cardiorenal Translat Lab, Madrid, Spain
[6] Inst Res Imas12, Hypertens Unit, Madrid, Spain
[7] Bayer AG, Stat & Data Insights, Wuppertal, Germany
[8] Bayer AG, Res & Early Dev, Wuppertal, Germany
[9] Bayer AG, Clin Res, Wuppertal, Germany
[10] Bayer AG, Med Affairs, Wuppertal, Germany
[11] Univ Chicago Med, Dept Med, Chicago, IL USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials
    Wujisiguleng Bao
    Mingzhu Zhang
    Ning Li
    Zhi Yao
    Luying Sun
    European Journal of Clinical Pharmacology, 2022, 78 : 1877 - 1887
  • [32] Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials
    Bao, Wujisiguleng
    Zhang, Mingzhu
    Li, Ning
    Yao, Zhi
    Sun, Luying
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1877 - 1887
  • [33] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23): : 2219 - 2229
  • [34] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes Reply
    Bakris, George L.
    Agarwal, Rajiv
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [35] Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
    Fu, Edouard L.
    Kutz, Alexander
    Desai, Rishi J.
    KIDNEY INTERNATIONAL, 2023, 103 (01) : 30 - 33
  • [36] A Systematic Review and Meta-Analysis on the Efficacy and Safety of Finerenone Therapy in Patients with Cardiovascular and Chronic Kidney Diseases in Type 2 Diabetes Mellitus
    Jyotsna, F. N. U.
    Mahfooz, Kamran
    Patel, Tirath
    Parshant, F. N. U.
    Simran, Fnu
    Harsha, Fnu
    Neha, Fnu
    Jyotishna, Dev
    Mishra, Dipesh
    Subedi, Sirjana
    Khatri, Mahima
    Kumar, Satesh
    Varrassi, Giustino
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [37] Finerenone: Efficacy of a New Nonsteroidal Mineralocorticoid Receptor Antagonist in Treatment of Patients With Chronic Kidney Disease and Type 2 Diabetes
    Dey, Subo
    Garg, Jasmine
    Wang, Andy
    Holzner, Eva
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2024, 32 (03) : 285 - 288
  • [38] The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease
    Vasco, Maria Adelaida Escobar
    Fantaye, Samuel H.
    Raghunathan, Sapna
    Solis-Herrera, Carolina
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4135 - 4146
  • [39] Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance
    Ebert, Thomas
    Anker, Stefan D.
    Ruilope, Luis M.
    Fioretto, Paola
    Fonseca, Vivian
    Umpierrez, Guillermo E.
    Birkenfeld, Andreas L.
    Lawatscheck, Robert
    Scott, Charlie
    Rohwedder, Katja
    Rossing, Peter
    DIABETES CARE, 2024, 47 (03) : 362 - 370
  • [40] Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus With Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials
    Yang, Shuai
    Shen, Wen
    Zhang, Hong-zhou
    Wang, Chen-xi
    Yu, Wan-qian
    Wu, Qing-hua
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 81 (01) : 55 - 62
12345